NOS2 and coronary artery disorder: For instance, NO-releasing nanoparticles have demonstrated therapeutic benefits in ischemic heart disease and wound healing, while liposomal formulations of iNOS inhibitors have shown efficacy in reducing inflammation in arthritis models.